Publicaciones en colaboración con investigadores/as de Karolinska University Hospital (33)

2024

  1. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

    Kidney International Reports

  2. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Annals of the Rheumatic Diseases

2023

  1. Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y)

    Nature Communications

  2. Corrigendum to ‘Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus’ [J. Autoimmun. 136 (April 2023) 103025] (Journal of Autoimmunity (2023) 136, (S0896841123000343), (10.1016/j.jaut.2023.103025))

    Journal of Autoimmunity

  3. Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 136

  4. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. Erratum: Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells (Nature communications (2022) 13 1 (4287))

    Nature communications

  3. Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells

    Nature Communications, Vol. 13, Núm. 1

2019

  1. Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 311-319

2017

  1. Transancestral mapping and genetic load in systemic lupus erythematosus

    Nature Communications, Vol. 8

2014

  1. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

    American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61

2012

  1. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 1, pp. 136-142

  2. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene

    Genes and Immunity, Vol. 13, Núm. 3, pp. 268-274

2010

  1. A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 62, Núm. 11, pp. 3404-3414

  2. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 62, Núm. 6, pp. 1702-1711

2009

  1. Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases

    Genes and Immunity, Vol. 10, Núm. 6, pp. 601-605

2008

  1. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in icelandic multicase systemic lupus erythematosus families

    Arthritis and Rheumatism, Vol. 58, Núm. 12, pp. 3865-3872

  2. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus

    Nature Genetics, Vol. 40, Núm. 2, pp. 211-216

  3. IFN-regulatory factor 5 gene variants interact with the class I MHC locus in the Swedish psoriasis population

    Journal of Investigative Dermatology, Vol. 128, Núm. 7, pp. 1704-1709